Lotti T, Ghersetich I, Comacchi C, Jorizzo J L
Department of Dermatology, University of Florence, Italy.
J Am Acad Dermatol. 1998 Nov;39(5 Pt 1):667-87; quiz 688-90. doi: 10.1016/s0190-9622(98)70039-8.
Cutaneous small-vessel vasculitis (CSVV) refers to a group of disorders usually characterized by palpable purpura; it is caused by leukocytoclastic vasculitis of postcapillary venules. CSVV can be idiopathic or can be associated with a drug, infection, or underlying systemic disease. Initially, the pathogenesis of CSVV is immune complex related, but in its later stages different pathogenetic mechanisms may intensify the reaction and lymphocytes may predominate in the infiltrate. Cure requires elimination of the cause (ie, drugs, chemicals, infections, food allergens) when possible, as well as therapy with nonsteroidal antiinflammatory agents, corticosteroids, dapsone, potassium iodide, fibrinolytic agents, aminocaproic acid, immunosuppressive agents (ie, cyclophosphamide, azathioprine, methotrexate, cyclosporine) or even monoclonal antibodies, depending on disease severity.
皮肤小血管炎(CSVV)是指一组通常以可触及性紫癜为特征的疾病;它由毛细血管后微静脉的白细胞破碎性血管炎引起。CSVV可以是特发性的,也可与药物、感染或潜在的全身性疾病相关。最初,CSVV的发病机制与免疫复合物有关,但在后期不同的发病机制可能会加剧反应,且浸润中淋巴细胞可能占主导。治愈需要尽可能消除病因(即药物、化学物质、感染、食物过敏原),以及根据疾病严重程度使用非甾体抗炎药、皮质类固醇、氨苯砜、碘化钾、纤溶药物、氨基己酸、免疫抑制剂(即环磷酰胺、硫唑嘌呤、甲氨蝶呤、环孢素)甚至单克隆抗体进行治疗。